There is evidence for sex-related differences in the cardiovascular actions of vasopressin. Furthermore, receptors for the gonadal steroid hormones are located in centers in the brain involved in the control of vasopressin release and in cardiovascular regulation. We have, therefore, examined the effects of hemorrhage on mean arterial blood pressure, the plasma vasopressin concentration, and plasma renin concentration in conscious male and female rats.
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There is evidence for sex-related differences in the cardiovascular actions of vasopressin. Furthermore, receptors for the gonadal steroid hormones are located in centers in the brain involved in the control of vasopressin release and in cardiovascular regulation. We have, therefore, examined the effects of hemorrhage on mean arterial blood pressure, the plasma vasopressin concentration, and plasma renin concentration in conscious male and female rats.
In preliminary experiments, no differences were found in blood and plasma volumes with respect to either sex or phase of the estrous cycle. In separate experiments, rats were subjected to two hemorrhages of 10% of blood volume, separated by an interval of 15 minutes. There were no substantial genderor cycle-related differences in the ability of hemorrhaged rats to maintain mean arterial blood pressure or increase plasma renin concentration. The increase in plasma vasopressin concentration was greater in proestrous females than in males after the first hemorrhage and in diestrous, proestrous, and metestrous females than in males after the second hemorrhage. Pretreatment with a V1-receptor antagonist was without statistically significant effect on the mean arterial blood pressure responses in males, but it impaired blood pressure compensation in females. There are, then, genderand cycle-related differences in vasopressin responses to hemorrhage, and vasopressin appears particularly important for blood pressure compensation to hemorrhage in female rats. (Circulation Research 1990; 66:1345 -1353 It is well established that a reduction in blood volume is a potent stimulus for the release of vasopressin.' The presence of androgen and estrogen receptors in centers in the medulla involved in the regulation of arterial blood pressure and the control of vasopressin release23 and in the anterior hypothalamus and posterior pituitary4-6 suggests that there may be sex-related differences in the vasopressin and cardiovascular responses to hemorrhage. Furthermore, there is considerable evidence that vasopressin contributes to the maintenance of arterial blood pressure after hemorrhage.1 The reports that there are sex-related differences in the effects of vasopressin on arterial blood pressure7,8 and that estradiol can modulate the vasoconstrictor actions of vasopressin9410 and catecholamines9 suggest that there may also be sex-related differences in the role of vasopressin in the cardiovascular responses to hemorrhage.
To examine these issues, we have determined the effects of hemorrhage on the release of vasopressin in conscious unrestrained male rats and female rats in each phase of the estrous cycle. A vasopressin V1 receptor antagonist was administered to determine the contribution of vasopressin to the maintenance of arterial blood pressure after hemorrhage.
Materials and Methods

Animal Preparation
The experiments were carried out in conscious, unrestrained, age-matched (9-12 weeks old) male and female Sprague-Dawley rats (Harlan Sprague-Dawley, Indianapolis, Indiana). The rats were housed in individual cages in a room with controlled light (12 hours on, 12 hours off) and temperature (220 C) and had free access to food and water.
Female rats were used after at least one, and usually two, complete estrous cycles, which were identified by vaginal smear. The day before the experiment, the rats were anesthetized with ether, and PE-50 polyethylene catheters, pulled to a fine tip, were placed in a femoral artery and vein. To ensure normal fluid balance after surgery, the rats were given access to 20 ml of a 5% dextrose solution in addition to the regular drinking water. Rats with impaired fluid intake were not used. The experiments were carried out in a quiet room, while the rats were in plastic boxes, 12x14x25 cm, that allowed them to move forward and backward and to turn around. The floor of the box was made of stainless steel screening, the cover of the box was perforated to allow adequate ventilation, and there was a slot along the top of the box to allow free movement of the catheters.
Measurement of Blood Volume
In these experiments, the placement of a catheter in a femoral vein was omitted. Plasma volume was measured in male rats and in female rats in each phase of the estrous cycle by an indicator-dilution technique described in detail previously.11 After an initial blood sample of 0.15 ml was taken for the measurement of hematocrit, 0.5 ml of a 0.9% NaCl-0.025% bovine serum albumin solution containing approximately 1 ,uCi of radioiodinated (1251) serum albumin (RISA, Mallinkrodt, St. Louis, Missouri) was injected intraarterially. The syringe and catheter were rinsed by injecting an additional 0.3 ml of the saline-albumin solution. Blood samples (0.15 ml each) were taken 30, 60, 90, and 120 minutes after the injection of the RISA. Radioactivity was measured in 20-and 50-,ul aliquots of plasma, separated from the blood samples by centrifugation, with an Apex Automatic Gamma Counter (Micromedic Systems, Horsham, Pennsylvania). Regression analysis was used to estimate the plasma concentration of 1251 at zero time. Plasma volume was calculated by dividing the amount of RISA injected, estimated by counting five 10-gl aliquots of the injectate, by the zero-time plasma concentration of 1251. Blood volume was estimated by dividing plasma volume by (1 -hematocrit).
Hemorrhage Protocol
Mean arterial blood pressure (MABP) was measured from the femoral arterial catheter with a Statham P23 ID strain gauge transducer (Statham, Oxnard, California) and a Gould Brush 2600 recorder (Gould, Cleveland, Ohio). Heart rate was recorded from the arterial pulse with a Gould Brush Biotach. MABP and heart rate were measured every 30 seconds, digitized with an analog-to-digital converter and an Apple Two Plus computer (Apple, Cupertino, California), and averaged over 5-minute intervals throughout the experiment. After an acclimatization period of 20-25 minutes, an initial arterial blood sample of 2.5 ml was taken into a heparinized plastic syringe for the measurement of the plasma concentrations of vasopressin, sodium, potassium, protein, plasma osmolality, and hematocrit. An additional 0.5-ml sample was taken into a plastic syringe containing 20 pi1 of 4% sodium EDTA in 0.9% NaCl for the measurement of the plasma renin concentration (PRC). The blood taken for these and subsequent blood samples was replaced by the simultaneous intravenous injection of an equal volume of rat donor blood, obtained by decapitation on the morning of the experiment. Donor blood was warmed to 370 C just before use. The rats were then subjected to two hemorrhages, 10 and 25 minutes after the initial blood sample. Each hemorrhage was 10% of the average blood volume for that group of animals, as determined in the previous series of experiments. Additional blood samples were taken 10 minutes after each hemorrhage for the measurement of vasopressin, renin, plasma protein, and hematocrit.
In order to determine the contribution of vasopressin to the maintenance of MABP when blood volume is reduced, 10 ,g/kg body wt of the vasopressin V, antagonist 8-mercapto-3,,3-cyclopentamethylenepropionic acid',O-methyl-Tyr2,Arg8 was given intravenously 5 minutes before the first hemorrhage in a separate series of experiments. The protocol was identical to that in which the antagonist was not given.
Analytical Procedures
The method for measurement of vasopressin has been described in detail previously.12 Briefly, vasopressin was extracted from plasma with C18 cartridges (Sep-Pak, Waters Associates, Millford, Massachusetts) and measured by radioimmunoassay under disequilibrium conditions with the United States Pharmacopeia Posterior Pituitary Reference Standard as the standard. Recovery of vasopressin from rat plasma was 85.2+0.7%; the withinand betweenassay coefficients of variability were 4.3 +0.7% and 5.0%, respectively.
For the measurement of PRC, plasma rich in renin substrate was obtained from rats 48 hours after bilateral nephrectomy. The following reagents were added to 150 ml of this plasma: 1.5 ml of 0.7% dimercaprol, 1.5 ml of 6.6% 8-hydroxyquinoline, 1.5 ml of 2.5% phenylmethylsulfonyl fluoride in ethanol, and 15 ml of 1% neomycin-1% thimerosal. This plasma mixture was adjusted to pH 6.0 with HCl. To 1 ml of this plasma mixture and 1 ml of 0.2 M maleate buffer adjusted to pH 6.0, in an ice bath, 100 ,l of plasma sample was added. A portion (0.7 ml) of this mixture was incubated at 4°C, and the remainder was incubated at 370 C. After 3 hours, the generation of angiotensin I was terminated by placing the test tubes in a boiling water bath for 5 minutes. Angiotensin I was measured by radioimmunoassay with an angiotensin I radioimmunoassay kit (Rianin, New England Nuclear, North Billerica, Massachusetts).
Plasma osmolality and the plasma concentrations of sodium and potassium were measured with an Advanced Micro-Osmometer (model 3 MO, Advanced Instruments, Needham Heights, Massachusetts) and IL343 flame photometer (Instrumentation Laboratories, Lexington, Massachusetts), respectively. Hematocrit was measured with a microcapillary technique. The plasma protein concentration was determined by refractometry with an AO Reichert TS meter (AO Reichert Instruments, Buffalo, New York). 
Statistics
Data were analyzed statistically by one-way analyses of variance. Plasma vasopressin values were first subjected to a logarithmic transformation because of nonhomogeneity of variance. Specific differences were identified with a Newman-Keuls test. Data in the text, figures, and tables are given as mean+SEM.
Results
Blood Volume
The male rats weighed appreciably more than age-matched females in any of the phases of the estrous cycle (Table 1) . For this reason, blood and plasma volumes were corrected for body weight. When this was done, there were no differences in these variables with respect to sex of the rat or phase of the estrous cycle (Table 1) . Hematocrit (Table 1) was higher in the male than in the female rats; this difference was statistically significant for all groups of females (p<0.05) except diestrus.
Effects of Hemorrhage
Before hemorrhage, plasma osmolality ( Table 2 ) was higher in males than in estrous and metestrous females (p<O.05), and hematocrit ( Table 2) was higher in males than in diestrous (p<0.01), proestrous (p<0.01), and estrous (p<0.05) females.
There were no differences among the groups with respect to initial MABP (Table 3 ) and the plasma concentrations of sodium (Table 3) , potassium (Table 3) , and protein ( Table 2 ). Basal heart rate was somewhat higher in the females than the males (Table 3 ), but this difference was not statistically significant.
There were no statistically significant changes in MABP in any of the groups of rats in response to the ip<O.O5 different from males. Changes in mean arterial bloodpressure (AMABP) after two hemorrhages of 10% of the initial blood volume (Hi and H2) in male rats and in female rats in each phase of the estrous cycle. MABP before HI is shown in Table 3 . first hemorrhage of 10% of the blood volume ( Figure  1 ), although there was some tendency for MABP to fall in the females, particularly those in proestrus. Thus, 10 minutes after the first hemorrhage, just before the first posthemorrhage blood sample, MABP in proestrous females was significantly lower than in the males and metestrous females (p<0.05). Fifteen minutes after the first hemorrhage, just before the second hemorrhage, MABP was at control levels in the males, but was 4-11 mm Hg below basal values in the four groups of females.
In contrast to the response to the first hemorrhage, the second hemorrhage of 10% of blood volume caused a marked fall in MABP in all of the rats in the 5-minute interval after the removal of the blood (Figure 1 ). The magnitude of this reduction in MABP from the level immediately preceding the second hemorrhage was similar in all of the groups of rats: 55±5 mm Hg in males, 47±12 mm Hg in diestrus, 56+6 mm Hg in proestrus, 43+4 mm Hg in estrus, and 50±4 mm Hg in metestrus. Furthermore, there were no statistically significant differences in absolute values for MABP among any of the groups. After the initial 5-minute period following the second hemorrhage, there was a return in MABP, which 
Changes in heart rate (AHR) after two hemorrhages of 10% of the initial blood volume (Hi and H2) in male rats and in female rats in each phase of the estrous cycle. HR before HI is shown in Table 3 .
reached prehemorrhage levels in all of the groups of females, but not in the males, 15 minutes after the second hemorrhage. Heart rate (Figure 2 ) after the first hemorrhage was unchanged in the males and estrous and metestrous females, but tended to increase in diestrous females and to decrease in proestrous females. Although these changes were not statistically significant, heart rate was significantly lower in proestrous females than in the other groups of rats (p<0.05 to p<0.01) 10 minutes after the hemorrhage. Five minutes after the second hemorrhage, there was a marked fall in heart rate in all of the rats (p<0.001). There was then a modest return in heart rate toward prehemorrhage levels in all of the rats except diestrous females.
Under basal conditions, there were no differences in plasma vasopressin concentrations (PAVP) with respect to either sex or phase of the estrous cycle ( Figure 3 ). The initial hemorrhage of 10% of the blood volume resulted in a 50% increase in the PAVP in the males (p<0.01) and a much larger increase in females (p<0.001) in proestrus, estrus, and metestrus; the increase in vasopressin in diestrous females was not statistically significant. These sexrelated differences were statistically significant (p<0.01) only when proestrous females, in which there was an eightfold increase in PAVP, were compared with the males and diestrous females. The second hemorrhage, which was markedly hypotensive, caused substantial increases in PAVP in all the rats (p<0.001). However, these increases were two to three times greater in diestrous, proestrous, and metestrous females than in the males (p<0.05). The rise in the PAVP in the estrous females was similar to that in the males but was not significantly different from PAVP in the other groups of females. PRC (Figure 4 ) increased moderately in all rats in response to the first hemorrhage and to a greater extent after the second hemorrhage. There were no sex-or cycle-related differences in this response.
Step.vise hemorrhage resulted in stepwise reductions in the plasma protein concentration and hematocrit ( Table 2) , but there were no differences in these changes with respect to either sex or phase of the estrous cycle. Plasma osmolality was unaffected by the initial hemorrhage but was increased by the second hemorrhage (Table 2 ). This response was also unaffected by the sex of the rat or the phase of the estrous cycle.
To determine whether there are sex-related differences in the contribution of vasopressin to the maintenance of blood pressure after a reduction in blood volume, male and female rats were given a vasopressin V1-receptor antagonist before the first of the two hemorrhages. The females were divided into two groups, those in proestrus and those in the other phases of the estrous cycle; in the previous series of experiments, proestrous rats were less able to maintain MABP after the first hemorrhage than the other females. After each of the two hemorrhages, MABP in the rats given the V1 blocker was lower than in the untreated rats (Table 4 ). However, this difference was statistically significant for the females not in proestrus 5, 10, and 15 minutes after the second hemorrhage (p<0.05 top<0.01), and for proestrous females 15 minutes after the first (p<0.05) and second (p<0.01) hemorrhage. The posthemorrhage changes in MABP in male rats treated with the V1 blocker were not significantly different from the changes in untreated males. Pretreatment with the V1 antagonist was without effect on the changes in heart rate that followed hemorrhages of 10% and 20% of the blood volume in male and proestrous female rats (Table 5 ). In the group of females in the other phases of the estrous cycle, however, blockade of the V1 receptors resulted in lower heart rates 5, 10, and 15 minutes after the first hemorrhage and 10 minutes after the second hemorrhage (p<0.05 to p<0.01; Table 5 ).
Discussion
The data presented here deal with the effects of gender and phase of the estrous cycle on the blood volume-blood pressure control of vasopressin release and on the role of vasopressin in the cardiovascular responses to acute hemorrhage. With respect to the former, our findings indicate that there are important cycleand sex-related differences in the blood volume-blood pressure control of vasopressin release and that the nature of these differences depends on the magnitude of the reduction in blood volume. A reduction in blood volume of 10% resulted in a much larger increase in PAVP in proestrous females than in males and diestrous females. In rats, the arterial baroreceptors appear to be particularly important in the vasopressin response to hemorrhage, because a large increase in PAVP does not occur unless the hemorrhage is accompanied by a large decrease in blood pressure (e.g., see References 13 and 14). Thus, the most obvious explanation for the differences in vasopressin response to a 10% hemorrhage in the present report is that, after this hemorrhage, MABP was significantly lower in the proestrous females than in the diestrous females and males. When the rats were again bled 10% of the initial blood volume, there was a different pattern in the vasopressin responses. Then, the increases in plasma vasopressin levels were much greater in the diestrous, proestrous, and metestrous females than in the males and estrous females. These differences could not be attributed to differences in MABP, because the changes in MABP that followed the second hemorrhage were similar in all groups of rats. What, then, could account for these substantial cycleand sex-related differences in the vasopressin response? These differences are unlikely to be due to differences in baroreceptor function, because we have found that baroreceptor sensitivity is similar in male rats and in female rats in each of the phases of the estrous cycle.8'15 Although the renin-angiotensin system may play a role in the control of vasopressin release, it is unlikely that this is a factor in the present experiments, since the increases in PRC after each hemorrhage were similar in the male and female rats.
As early as 10 minutes after the first 10% hemorrhage, the hematocrit and the plasma protein concentration began to fall, indicating that a net movement of interstitial fluid into the vascular compartment had begun. There were, however, no differences in this effect with respect to either gender or phase of the estrous cycle. Consequently, differences in the posthemorrhage restoration of blood volume could not have been a factor in sexand cycle-related differences in the vasopressin response to hemorrhage. It is possible that, after the second hemorrhage, there were cycle-and gender-related differences in the activity of the low-pressure, atrial receptors involved in the control of vasopressin release. This seems unlikely, since the initial reduction in blood volume and the subsequent restoration of blood volume were similar in each group of rats, and blood volume is an important determinant of the activity of atrial receptors.
An attractive explanation for the differences with respect to sex and phase of the estrous cycle in the vasopressin response to graded hemorrhage is that the gonadal steroid hormones may modulate the activity of the central nervous system components of the blood volume-blood pressure control of vasopressin release. There are estrogen and androgen receptors 1) in centers in the medulla that may participate in this component of the control of vasopressin release and in cardiovascular regulation2'3 and 2) in nuclei of the hypothalamus involved in vasopressin release into the circulation.4,5 The cycledependent changes in secretion of the ovarian hormones in the rat are consistent with this hypothesis. During metestrus, the plasma concentrations of estradiol and progesterone begin to rise and reach a minor peak at the beginning of diestrus; major peaks in the plasma levels of those hormones are achieved in proestrus.16 Rats in these three phases of the estrous cycle had the highest plasma concentrations of vasopressin after the 20% hemorrhage. As evidence that the gonadal hormones can modulate the central control of vasopressin release, we have found17 that the ability of centrally administered norepinephrine to stimulate vasopressin release is greater in male than in female rats and in females in proestrus than in the other phases of the estrous cycle. On the other hand, a report by Barron et al18 is not consistent with this hypothesis. These investigators reported that treatment of female rats with estradiol was without effect on the stimulation of vasopressin release when blood volume was reduced 5% to 17% by the intraperitoneal administration of polyethylene glycol. There are, however, substantial differences between the protocol of Barron et al and that used in the present experiments. In the former, males were not studied, the phase of the estrous cycle in the untreated females was not reported, the reduction in blood volume occurred over a much longer period of time (2 hours), and the maximum reduction in blood volume was smaller.
It is generally considered that vasopressin plays an important role in blood pressure compensation after hemorrhage. Thus, plasma vasopressin levels achieved in response to moderate to severe hemorrhage are high enough to raise blood pressure in normal animals.8 In addition, it has been reported that blood pressure compensation after hemorrhage is impaired in animals either with surgical19 or hereditary diabetes insipidus20-22 or that have been treated with a vasopressin V1 antagonist. 20, 21, [23] [24] [25] [26] To some extent, the present data are consistent with the view that vasopressin participates in the cardiovascular compensation to hemorrhage. After the second 10% hemorrhage, the initial fall and subsequent recovery of MABP were similar in all of the rats, regardless of gender and phase of the estrous cycle, even though the rise in PAVP was much greater in diestrous, proestrous, and metestrous females than in estrous females or males. This is consistent with our observation8 that the pressor responsiveness to vasopressin is much greater in estrous females and males than in females in the other phases of the cycle. Thus, in these latter groups of females, higher PAVP would be required to achieve the same level of blood pressure compensation as in the males and estrous females. In addition, pretreatment of female rats with a V1-receptor antagonist impaired the recovery of blood pressure after hemorrhage, even though the initial fall in MABP after hemorrhage was unaffected. This observation is similar to that of Johnson et al,25 who also used female rats, and Zerbe et al,21 who did not specify the sex of the rats that were used.
On the other hand, it was surprising that pretreatment of male rats with the V1-receptor antagonist had no statistically significant effect on the changes in MABP that followed hemorrhages of 10% and 20% of blood volume. However, previous reports have not clearly established an effect of V,-receptor blockade on the blood pressure responses to a reduction in blood volume in male rats. Thus, Johnson et a125 used only female rats. In the studies by Chapman et al, 20 Zerbe et al,21 and Pang,26 the rats were studied under anesthesia, and the sex of the rats was not specified. If only female rats were used in these last three studies, their findings would be consistent with ours. A recent report by Gardiner and Bennett27 is in agreement with our present findings. In conscious male rats, the blood pressure response to a reduction in blood volume induced by subcutaneous polyethylene glycol was unaffected by pretreatment with a V1-receptor antagonist. In the one report in which V, blockade clearly impaired blood pressure compensation after hemorrhage23 in male rats, the protocol differed importantly from ours. The V1 antagonist was not given until 30 minutes after a single hemorrhage of approximately 20% of blood volume, whereas our rats were only monitored for a total of 30 minutes after the first of the two hemorrhages.
The failure of V, blockade to affect the initial posthemorrhage fall in MABP in male and female rats and the subsequent compensation in MABP in the male rats does not necessarily mean that vasopressin does not normally participate in these phases of the cardiovascular adjustments to blood volume reduction. It is reasonable to consider that, after V1 blockade, the lack of the vasoconstrictor activity of vasopressin is compensated for by increased activity of the renin-angiotensin system and/or the sympathetic nervous system. Furthermore, while vasopressin is a potent vasoconstrictor, it also decreases cardiac output (for review, see Reference 1) and inhibits renin release.28 These latter two actions, which should impede cardiovascular adjustment to blood volume reduction, are also blocked by V1receptor antagonists. 29, 30 In the present experiments, hemorrhage of 20% of the blood volume resulted in a reduction in heart rate. This effect is characteristically seen in the rat (e.g., see References 20, 21, and 25) and has also been reported to follow severe or rapid hemorrhage in the dog,31 cat,32 and humans.33 This bradycardia is not due to vasopressin, because it was not prevented by V1 blockade in the present and previous20,2125 investigations and because it also occurred in rats with hereditary diabetes insipidus. 21 Oberg and White32 have presented evidence that this phenomenon is due to a vago-vagal reflex, which they suggested results from the stimulation of cardiac receptors when very poor diastolic filling is combined with sympathetic stimulation of the heart. In the present experiments, V1 blockade enhanced the hemorrhageinduced bradycardia in females not in proestrus. We have no explanation for this effect.
In conclusion, we have shown that male and female rats are able to maintain blood pressure equally well in the face of moderate and severe hemorrhage. There are, however, substantial gender-related and estrous cycle-related differences in the vasopressin response to hemorrhage, which are consistent with the gender-related and estrous cycle-related differences in the pressor responsiveness to vasopressin.
Finally, vasopressin is essential for the blood pressure compensation to hemorrhage in female rats, but this does not appear to be the case for male rats.
